Oncolytics Biotech Inc. (ONCY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Oncolytics Biotech Inc.

    NASDAQ: ONCY · Real-Time Price · USD
    1.06
    -0.02 (-1.85%)
    At close: Sep 05, 2025, 3:59 PM
    1.06
    0.00%
    After-hours: Sep 05, 2025, 07:29 PM EDT

    Oncolytics Biotech Balance Sheet Statement

    Financials in CAD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 15.94M 34.91M 11.67M 41.26M
    Short-Term Investments
    		 n/a 3.38M 20.47M 1.36M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a 998K n/a
    Receivables
    		 68K 15K 521K n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 980K n/a n/a n/a
    Total Current Assets
    		 18.88M 38.17M 35.68M 44.9M
    Property-Plant & Equipment
    		 1.31M 647K 652K 976.29K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 1.31M 647K 1.65M 976.29K
    Total Assets
    		 20.19M 38.82M 37.33M 45.88M
    Account Payables
    		 1.09M 1.08M 2.25M 594K
    Deferred Revenue
    		 n/a n/a n/a -594K
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 1.62M 532K 79K 407.84K
    Total Current Liabilities
    		 6.69M 4.24M 3.94M 2.69M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a 6.73M n/a
    Total Long-Term Liabilities
    		 7.52M 7.02M 6.89M 7.09M
    Total Liabilities
    		 14.2M 11.26M 10.83M 9.78M
    Total Debt
    		 1.06M 423K 373K 654.75K
    Common Stock
    		 438.19M 430.91M 404.04M 391.35M
    Retained Earnings
    		 -477.71M -446M -418.25M -393.42M
    Comprehensive Income
    		 961K 544K 662K 387.74K
    Shareholders Equity
    		 5.98M 27.56M 26.5M 36.1M
    Total Investments
    		 n/a 3.38M 20.47M 1.36M

    Add to Watchlist